Sign in
Ibrutinib therapy is effective in B-cell prolymphocytic leukemia exhibiting MYC aberrations
Journal article   Peer reviewed

Ibrutinib therapy is effective in B-cell prolymphocytic leukemia exhibiting MYC aberrations

Moussab Damlaj, Mohammed Al Balwi and Areej M. Al Mugairi
Leukemia & lymphoma, Vol.59(3), pp.739-742
04/03/2018
PMID: 28695755

Abstract

Hematology Life Sciences & Biomedicine Oncology Science & Technology

Metrics

1 Record Views

Details